Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


06.11.2017

1 Exp Brain Res
1 J Biol Chem
1 J Neural Transm (Vienna)
2 J Neurol Neurosurg Psychiatry
5 Mov Disord
1 Nat Neurosci
1 Neurology
1 Neurosci Lett
1 Neuroscience
3 PLoS One
2 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Exp Brain Res

  1. WARABI T, Furuyama H, Sugai E, Kato M, et al
    Gait bradykinesia in Parkinson's disease: a change in the motor program which controls the synergy of gait.
    Exp Brain Res. 2017 Oct 27. doi: 10.1007/s00221-017-5106.
    PubMed     Text format     Abstract available


    J Biol Chem

  2. LANDAU M
    Getting in charge of beta-synuclein fibrillation.
    J Biol Chem. 2017;292:16380-16381.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. TSUBOI T, Watanabe H, Tanaka Y, Ohdake R, et al
    Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    J Neural Transm (Vienna). 2017 Nov 2. doi: 10.1007/s00702-017-1804.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  4. RICCIARDI L, Lambert C, Micco R, Morgante F, et al
    Can we predict development of impulsive-compulsive behaviours in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2017 Oct 27. pii: jnnp-2017-317007.
    PubMed     Text format     Abstract available

  5. FANTINI ML, Figorilli M, Arnulf I, Zibetti M, et al
    Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.
    J Neurol Neurosurg Psychiatry. 2017 Oct 24. pii: jnnp-2017-316576.
    PubMed     Text format     Abstract available


    Mov Disord

  6. FASANO A, Canning CG, Hausdorff JM, Lord S, et al
    Falls in Parkinson's disease: A complex and evolving picture.
    Mov Disord. 2017 Oct 25. doi: 10.1002/mds.27195.
    PubMed     Text format     Abstract available

  7. STANDAERT DG
    What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's disease.
    Mov Disord. 2017;32:1341-1342.
    PubMed     Text format    

  8. METEREAU E, Beaudoin-Gobert M, Duperrier S, Thobois S, et al
    Diffusion tensor imaging marks dopaminergic and serotonergic lesions in the Parkinsonian monkey.
    Mov Disord. 2017 Oct 27. doi: 10.1002/mds.27201.
    PubMed     Text format     Abstract available

  9. LI W, Lao-Kaim NP, Roussakis AA, Martin-Bastida A, et al
    11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
    Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27183.
    PubMed     Text format     Abstract available

  10. SOHAIL S, Yu L, Schneider JA, Bennett DA, et al
    Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease.
    Mov Disord. 2017 Oct 30. doi: 10.1002/mds.27200.
    PubMed     Text format     Abstract available


    Nat Neurosci

  11. ROY S
    Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease.
    Nat Neurosci. 2017;20:1514-1515.
    PubMed     Text format    


    Neurology

  12. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Text format     Abstract available


    Neurosci Lett

  13. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Text format     Abstract available


    Neuroscience

  14. CRONIN A, Grealy M
    Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson's Disease.
    Neuroscience. 2017 Oct 24. pii: S0306-4522(17)30746.
    PubMed     Text format     Abstract available


    PLoS One

  15. PERJU-DUMBRAVA L, Lau K, Phyland D, Papanikolaou V, et al
    Arytenoid cartilage movements are hypokinetic in Parkinson's disease: A quantitative dynamic computerised tomographic study.
    PLoS One. 2017;12:e0186611.
    PubMed     Text format     Abstract available

  16. MINATO T, Maeda T, Fujisawa Y, Tsuji H, et al
    Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
    PLoS One. 2017;12:e0187307.
    PubMed     Text format     Abstract available

  17. MORISHITA T, Hilliard JD, Okun MS, Neal D, et al
    Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
    PLoS One. 2017;12:e0183711.
    PubMed     Text format     Abstract available


    Rev Neurol

  18. DE YEBENES JG
    [Cervantes and Parkinson's disease].
    Rev Neurol. 2017;65:432.
    PubMed     Text format    

  19. DE FABREGUES O, Gironell A, Rossello-Jimenez D, Regueras E, et al
    [Movement disorders units and management of motor fluctuations in advanced Parkinson's disease].
    Rev Neurol. 2017;65:396-404.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: